⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNSE News
Sensei Biotherapeutics, Inc. Common Stock
Form 8-K
sec.gov
SNSE
FTH
Form 8-K
sec.gov
SNSE
Form 8-K
sec.gov
SNSE
Form 8-K
sec.gov
SNSE
Form 8-K
sec.gov
SNSE
Form 8-K
sec.gov
SNSE
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
businesswire.com
SNSE
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
globenewswire.com
GTBP
VIR
ONCY
SNSE
Form 8-K
sec.gov
SNSE
Form 8-K/A
sec.gov
SNSE